Nutrient restriction in combinatory therapy of tumors


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The main objective of anticancer treatment is the elimination of degenerated cells by the induction of programmed cell death. Various chemotherapy drugs and radiation are able to activate cell death mechanisms in tumors. However, unfortunately, monotherapy will always be insufficiently effective because of the variety and virulence of tumors, as well as their ability to develop resistance to drugs. Moreover, monotherapy might constrain many negative side effects. Therefore, the combination of different approaches and/or drugs will increase the efficiency of treatment. One such promising approach is the combination of nutrient restriction (NR) and various chemotherapeutic drugs. This approach may not only affect the autophagy but also influence apoptotic cell death. This review is focused on the potential of NR use in anticancer therapy, as well as the molecular mechanisms underlying this approach.

作者简介

V. Senichkin

Faculty of Basic Medicine

Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991

G. Kopeina

Faculty of Basic Medicine

Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991

A. Zamaraev

Faculty of Basic Medicine

Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991

I. Lavrik

Faculty of Basic Medicine; Department of Translational Inflammation Research

Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991; Magdeburg, 39120

B. Zhivotovsky

Faculty of Basic Medicine; Institute of Environmental Medicine, Division of Toxicology

编辑信件的主要联系方式.
Email: Boris.Zhivotovsky@ki.se
俄罗斯联邦, Moscow, 119991; Stockholm, 17177

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2016